The Florida-based clinician shares perspective and insight into what should be prioritized or revised in specialty care.
Public lifts on business and area closures due to the coronavirus 2019 (COVID-19) pandemic response are beginning to occur. Though clinical practices have largely converted to telemedicine platforms since March, some specialists with higher-priority patients are making the move to reopen their in-person practice in the near future.
HCPLive® advisory board member Brad Glick, DO, FAAD, of the Glick Skin Institute in Miami, FL, is among those clinicians. And though there is state- and organization-based guidance for him and his colleagues to follow in reopening their dermatology practice, there’s a lot of decision-making that is intuitive or dependent on the team.
In an interview with HCPLive, Glick discussed the role of institutions including the American Academy of Dermatology (AAD) in setting guidance for non-COVID-19 specialist care, the precautions and priorities being adopted by specialists to assure they can meet with the necessary patients, and the focus on assuring invasive care-eligible patients with growths or possible cancers are safely and confidently meeting with their dermatologist during the pandemic.
“Even if we wanted to, some of the patients didn’t want to come in,” he explained. “I think mostly, in the next weeks, we’ve got to get our patients back in and get some of the procedures done that they need.”